Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of NOV-002 plus paclitaxel/carboplatin in advanced non-small cell lung cancer
2006-001990-32Phase 3Completed
- Sponsor
- Cellectar Biosciences
- Start
- May 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of glutathione disulfide in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Cellectar Biosciences. Primary endpoint: Primary efficacy outcome. Started May 2007; status: completed.
02
Drugs
glutathione disulfide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-001990-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001990-32.